Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Condition(s):Hematogenously Acquired Staphylococcus Aureus Osteomyelitis; Bone Infection; OsteomyelitisLast Updated:November 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Hematogenously Acquired Staphylococcus Aureus Osteomyelitis; Bone Infection; OsteomyelitisLast Updated:November 2, 2021Completed
Condition(s):PneumoniaLast Updated:March 11, 2019Completed
Condition(s):Primary Immunodeficiency DiseaseLast Updated:January 27, 2022Completed
Condition(s):Atherosclerosis; Chlamydia Infections; Cytomegalovirus Infections; Pneumonia, Bacterial; PostmenopauseLast Updated:March 4, 2008Completed
Condition(s):Periodontitis; Rheumatoid ArthritisLast Updated:February 7, 2024Not yet recruiting
Condition(s):SARS-CoV-2 Infection; Covid19Last Updated:April 14, 2023Completed
Condition(s):Delirium; Anesthesia; Adverse EffectLast Updated:May 30, 2019Completed
Condition(s):Acute Hypoxemic Respiratory FailureLast Updated:November 1, 2007Unknown status
Condition(s):COVID19; BETA-CELL FUNCTIONLast Updated:May 10, 2023Completed
Condition(s):Antibiotic Resistance; Respiratory Tract Infections; Pediatric Infectious Disease; CRPLast Updated:April 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.